Dual Energy Spectral CT of Focal Liver Lesions in Advanced Cirrhosis: Early Experience

Similar documents
Dual Energy CT Aortography: Can We Reduce Iodine Dose??

Dual Energy CT of the Liver

Liver, Liver Fat, Fibrosis and HCC Screening with DECT

Gemstone Spectral Imaging quantifies lesion characteristics for a confident diagnosis

Dual-Energy CT: The Technological Approaches

8/3/2016. Consultant for / research support from: Astellas Bayer Bracco GE Healthcare Guerbet Medrad Siemens Healthcare. Single Energy.

Innovations in HCC Imaging: MDCT/MRI

Fused monochromatic imaging acquired by single source dual energy CT in hepatocellular carcinoma during arterial phase: an initial experience

Comparison of gastric vascular anatomy by monochromatic and polychromatic dual-energy spectral computed tomography imaging

HEPATO-BILIARY IMAGING

Imaging of liver and pancreas

Acknowledgments. A Specific Diagnostic Task: Lung Nodule Detection. A Specific Diagnostic Task: Chest CT Protocols. Chest CT Protocols

Role of DE-CT in Oncology

Emerging Applications in Musculoskeletal CT Imaging

TREATMENT FOR HCC AND CHOLANGIOCARCINOMA. Shawn Pelletier, MD

Selection Criteria and Insertion of SIRT into HCC Treatment Guidelines

Optimal Monochromatic Energy Levels in Spectral CT Pulmonary Angiography for the Evaluation of Pulmonary Embolism

Dual-Energy CT Applications in Radiation Therapy

ASU-Mayo Clinic Imaging Informatics Laboratory (AMIIL)

Contrast-Enhanced Digital Mammography

Ultrasound. Computed tomography. Case studies. Utility of IQon Spectral CT in. cardiac imaging

ESUR 2018, Sept. 13 th.-16 th., 2018 Barcelona, Spain

Customizing Contrast Injection for Body MDCT: Algorithmic Approach

Hepatobiliary Contrast Agents

HCC and mass effect. Hepatocellular cancer: what if the AFP is rising but no lesion seen on imaging? What you need to know about AFP.

40 th Annual Meeting of the SCBT/MR

Surveillance for Hepatocellular Carcinoma

The Focal Hepatic Lesion: Radiologic Assessment

Les Outils Cliniques de Demain en Scanner Cardiaque. Cardiaque Status en ECR 2018 From Diagnosis to Prognosis

Anatomical and Functional MRI of the Pancreas

LIVER IMAGING TIPS IN VARIOUS MODALITIES. M.Vlychou, MD, PhD Assoc. Professor of Radiology University of Thessaly

Alice Fung, MD Oregon Health and Science University

Hepatocellular Carcinoma: A major global health problem. David L. Wood, MD Interventional Radiology Banner Good Samaritan Medical Center

Compute-aided Differentiation of Focal Liver Disease in MR Imaging

State of the Art Imaging for Hepatic Malignancy: My Assignment

Dual-Energy 101: Principles, Methods and Dose

ENTEROCOLITIDES CAN YOU TELL THEM APART ON MDCT? Richard M. Gore, MD North Shore University Medical Center University of Chicago Evanston, Illinois

ADRENAL LESIONS 10/09/2012. Adrenal + lesion. Introduction. Common causes. Anatomy. Financial disclosure. Dr. Boraiah Sreeharsha. Nothing to declare

How do the Parameters affect Image Quality and Dose for Abdominal CT? Image Review

Dual Energy CT of the Heart: Perfusion and Beyond

Workup of a Solid Liver Lesion

SPECIFIC PRINCIPLES FOR DOSE REDUCTION IN HEAD CT IMAGING. Rajiv Gupta, MD, PhD Neuroradiology, Massachusetts General Hospital Harvard Medical School

NONINVASIVE IMAGING METHODS FOR ASSESSMENT OF LIVER DAMAGE IN NASH

A study on CT pulmonary angiography at low kv and low-concentration contrast medium using iterative reconstruction.

HCC RADIOLOGIC DIAGNOSIS

New Technologies for Cardiac CT. Geoffrey D. Rubin, MD, MBA, FACR, FNASCI Duke University

Simon Nepveu 1, Irina Boldeanu 1, Yves Provost 1, Jean Chalaoui 1, Louis-Mathieu Stevens 2,3, Nicolas Noiseux 2,3, Carl Chartrand-Lefebvre 1,3

What s New in Breast Imaging. Jennifer A. Harvey, M.D., FACR Professor of Radiology University of Virginia

Yoshihisa Tsuji, Naoki Takahashi, Joel G. Fletcher, David M. Hough, Brendan P. McMenomy, Cynthia H McCollough, Katharine L. Grant, Ernst Klotz

Learning Objectives. After attending this presentation, participants will be able to:

CT Perfusion. U. Joseph Schoepf, MD, FAHA, FSCBT MR, FSCCT Professor of Radiology, Medicine, and Pediatrics Director of Cardiovascular Imaging

Dual-Energy CT Applications in the Abdomen

CTA/MRA of Pediatric Hepatic Masses Radiology-Pathology Correlation

Low Dose Era in Cardiac CT

Spectral CT imaging as a new quantitative tool? Assessment of perfusion defects of pulmonary parenchyma in patients with lung cancer

9/10/2018. Liver Transplant for Hepatocellular Carcinoma (HCC): What is New? DISCLOSURES

Liver imaging the revolution

Liver transplantation: Hepatocellular carcinoma

Guidelines for SIRT in HCC An Evolution

COLORECTAL CANCER STAGING in 2010

Imaging Pancreatic Neuroendocrine Tumors (PNETs): CT, MRI, EUS, Nuclear

Hepatocellular Carcinoma: Diagnosis and Management

Certainty. lives in layers. Philips IQon Spectral CT. Computed tomography

Split-bolus spectral CT imaging of the pancreas

Evaluation of energy spectrum CT for the measurement of thyroid iodine content

Alessandro Albonico Philips

CT & MRI of Benign Liver Neoplasms Srinivasa R Prasad

True Dual Energy. Dr. Stefan Ulzheimer, Siemens Healthcare GmbH. DEfinitely Siemens

Surveillance for HCC Who, how Diagnosis of HCC Surveillance for HCC in Practice

Liver Tumors. Prof. Dr. Ahmed El - Samongy

Radiology of hepatobiliary diseases

Quantitatively Defining Washout in Hepatocellular Carcinoma

Biomarkers and the Future of. John R. Votaw CBIS 5 th Year Anniversary Celebration/Look to the future February 8, 2013

University of Groningen. Quantitative CT myocardial perfusion Pelgrim, Gert

Newcastle HPB MDM updated radiology imaging protocol recommendations. Author Dr John Scott. Consultant Radiologist Freeman Hospital

Evangelos Chartampilas Bioclinic Hospital Thessaloniki, Greece

Ultralow Dose Chest CT with MBIR

Scientific Exhibit. Authors: D. Takenaka, Y. Ohno, Y. Onishi, K. Matsumoto, T.

Hepatocellular carcinoma (HCC) is a malignant liver neoplasm

Monophasic versus biphasic contrast application in CT of patients with head and neck tumour

Low-Dose CT: Clinical Studies & the Radiologist Perspective

How to evaluate tumor response? Yonsei University College of Medicine Kim, Beom Kyung

Liver Transplantation for HCC Which Criteria?

EASL-EORTC Guidelines

5/26/10. Oren Fix, MD, MSc Transplant Hepatology Division of Gastroenterology University of California San Francisco

Acknowledgements. Update of Focal Liver Lesions Goals. Focal Liver Lesions. Imaging Choices For Liver Lesions. Focal Liver Lesions

Breast CT and Dosimetry

Pediatric chest HRCT using the idose 4 Hybrid Iterative Reconstruction Algorithm: Which idose level to choose?

STANDARDIZED MANAGEMENT RECOMMENDATIONS FOR ADRENAL NODULES: EVIDENCE-BASED CONSENSUS POWERSCRIBE MACROS FROM AN ACADEMIC/PRIVATE PRACTICE

Objectives. HCC Incidence and Mortality. Disclosure Statement HCC. Imaging of Hepatocellular Carcinoma. Treatment of Hepatocellular Carcinoma

MRI for HCC surveillance and reporting: LI-RADS. Donald G. Mitchell, M.D. Thomas Jefferson University Philadelphia, PA

To Shield or Not to Shield? Lincoln L. Berland, M.D.

Liver MRI in 30 minutes

UMHS-PUHSC JOINT INSTITUTE

Abdominal Solid Organ Injury

Ask EuroSafe Imaging. Tips & Tricks. CT Working Group

Dr Claire Smith, Consultant Radiologist St James University Hospital Leeds

Abdominal Solid Organ Injury

Information for patients (and their families) waiting for liver transplantation

Transcription:

Dual Energy Spectral CT of Focal Liver Lesions in Advanced Cirrhosis: Early Experience William P. Shuman MD, FACR University of Washington SCBTMR Annual Course Washington DC, October 23-26, 2011

Conflict of Interest Statement I administer a grant from GE Healthcare which supports clinical investigations in body CT No support for equipment or salaries

Model for End-stage Liver Disease MELD Score (6 40 points) Mayo Clinic 2000 Used to stratify patients waiting for liver transplant by medical urgency Based on lab data creatinine, tot. bilirubin, ratio

Model for End-stage Liver Disease MELD Score (6-40) No exception for stage 1 HCC (< 2cm) Exception for patients with stage T2 HCC Granted 24 extra points Goal: Waiting time for HCC = non-hcc Drop-out rates equal

UCSF-Expanded MELD Criteria Now (2010) includes Stage 3a by CT imaging criteria - hypervascular lesion in patients with end stage liver disease: Single lesion < 2 cm 6.5 cm 2-3 lesions each 4.5 cm total lesion diameter 8 cm No macrovascular invasion on CT Pomfret EA, Liver Transpl 2010; 16:262

Single Energy CT Early detection of small lesions is imperfect MR sensitivity outperforms CT by 10 15% Characterization of small lesions into cyst versus small tumor is difficult HU unreliable due to partial volume

Dual Energy: Potential Liver Applications Enhance the subtle lesion Tumor versus cyst Eliminate unenhanced phase Focal fat, Iron deposition Response to Y-90

Dual Energy Liver CT: History First published in 1980, Brit. Med. J. R.W.G. Chapman and Gram Bydder Dual Energy CT for liver iron content in hemochromatosis EMI 5005 140 and 110 kvp 20 seconds per slice CT estimates of iron content correlated closely with chemical analysis of biopsies

Dual Energy Liver CT: 2008 R. Nelson, MDCT, Las Vegas, 5/15/08

Dual Energy Liver CT: 2009 80 kvp 140 kvp D. Marin et al, Radiology, 2009

Dual Energy: The Big Questions Might late-arterial stage dual energy CT in patients with end stage liver disease improve hypervascular lesion (HCC) - Conspicuity of individual lesions Number of lesions detected Accuracy of measurements Characterization of lesions (washout)

DECT of Hypervasc. Liver Lesions 40 patients with HCC, 135 lesions (2011) 80 kvp 140 Averaged Mean # lesions 3.37 1.43 2.57 Total # lesions 135 57 103 HU (ave) 119 78 92 CNR 6.4 4.7 6.9 Image Quality poor fair excellent Altenbernd A, et al, Eur Radiology 2011 21: 738

Dual- vs. Single- Energy CT: Dose University of Washington experience: GE HD 750 with GSI CT of liver Single: ACTM NI=36, ASIR 40% DE GSI: ACTM NI=25, ASIR 30% (Fixed) Dual energy runs 15% higher dose than our routine clinical scanning (NI = 36) But user variable ASIR % coming

kev 140-40

Dual Energy Spectral Imaging: HCC Water only Iodine only

Dual Energy Spectral Imaging: HCC 70 kev

Dual Energy Spectral Imaging: HCC 40 kev 130 kev

Dual Energy Spectral Imaging: HCC 40 kev 60 kev

Dual Energy Spectral Imaging: HCC Water Only Iodine Only

Dual Energy Spectral Imaging: HCC 40 kev 110 kev

Dual Energy Spectral Imaging: HCC 40 kev 80 kev

40 kev 67 kev 50 kev 77 kev

Spectral GSI and Portal Venography 30 patients with portal hypertension 140 monochromatic plus polychromatic image sets Objective CNR and subjective image quality Optimal CNR at 51 kev 100% higher contrast than 120 kvp but 30% more noise Subjective image quality scores statistically best at 51 kev Zhao et al, Euro J. Radiol, 2011

51 kev 120 kvp Zhao et al, Euro J Radiol 2011

kev vs. CNR of Iodine : 51 kev Portal Vein (Zhao, EJR) Hypervasc. Liver Lesion (Mitsumori)

40 kev 51 kev 70 kev 77 kev

Hypodense Liver Lesions: Met vs. Cyst GSI Projection Based Dual Energy Hypodense Liver Lesions Santamaria-Pang, Hara, et al, Proc SPIE, 2010

Liver Fat Distribution and Quantification GSI Projection Based Dual Energy Kriston, Silva, Sahani, et al, SPIE 2010

Conclusion Dual energy spectral CT images of the liver show promise for improving focal lesion detection and characterization in cirrhosis. Impact on lesion staging - research Optimal kev may improve sensitivity May lead to earlier tumor detection May improve characterization of lesions